JERALD LOY: Open Payments
NPI 1104851021 · ALBUQUERQUE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$411 in 19 payments from 9 companies in 2025. Trend: 2023 $286 · 2024 $732 · 2025 $411
Food & beverage: $411
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 6 | $122 |
| AstraZeneca Pharmaceuticals LP | 2 | $115 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $49 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $29 |
| Exact Sciences Corporation | 2 | $29 |
| PFIZER INC. | 1 | $21 |
| Novo Nordisk Inc | 1 | $16 |
| GlaxoSmithKline, LLC. | 1 | $16 |
| Novartis Pharmaceuticals Corporation | 1 | $15 |
Products named: BREZTRI, MOUNJARO, KISUNLA, JARDIANCE, JOURNAVX, ZEPBOUND, PREVNAR 20, Ozempic.
Industry payments across NM — which companies pay providers there.
